News
Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...
Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...
For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.
For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.
Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...
Novo Nordisk (NVO) is offering a one-month reduction in the price of its blockbuster weight-loss GLP-1 drug, to help ...
News last week that a CNN investigative report found dozens of fake podcasts on the popular audio streaming and media service platform Spotify, illegally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results